Nitric oxide decreases endothelin-1 secretion through the activation of soluble guanylate cyclase

Lisa K. Kelly, Stephen Wedgwood, Robin H. Steinhorn, Stephen M. Black

Research output: Contribution to journalArticle

72 Citations (Scopus)

Abstract

The use of exogenous nitric oxide (NO) has been shown to alter the regulation of other endothelially derived mediators of vascular tone, such as endothelin-1 (ET-1). However, the interaction between NO and ET-1 appears to be complex and remains incompletely understood. One of the major actions of NO is the activation of soluble guanylate cyclase (sGC) with the subsequent generation of cGMP. Therefore, we undertook this study to test the hypothesis that NO regulates ET-1 production via the activation of the sGC/cGMP pathway. The results obtained indicated that the exposure of primary cultures of 4-wk-old ovine pulmonary arterial endothelial cells (4-wk PAECs) to the long-acting NO donor DETA NONOate induced both a dose- and time-dependent decrease in secreted ET-1. This decrease in ET-1 secretion occurred in the absence of changes in endothelin-converting enzyme-1 or sGC expression but in conjunction with a decrease in prepro-ET-1 mRNA. The changes in ET-1 release were inversely proportional to the cellular cGMP content. Furthermore, the NO-independent activator of sGC, YC-1, or treatment with a cGMP analog also produced significant decreases in ET-1 secretion. Conversely, pretreatment with the sGC inhibitor ODQ blocked the NO-induced decrease in ET-1. Therefore, we conclude that exposure of 4-wk PAECs to exogenous NO decreases secreted ET-1 resulting from the activation of sGC and increased cGMP generation.

Original languageEnglish (US)
Pages (from-to)L984-L991
JournalAmerican Journal of Physiology - Lung Cellular and Molecular Physiology
Volume286
Issue number5 30-5
DOIs
StatePublished - May 1 2004

Fingerprint

Endothelin-1
Nitric Oxide
Sheep
Endothelial Cells
Soluble Guanylyl Cyclase
Lung
Nitric Oxide Donors
Blood Vessels
Messenger RNA

Keywords

  • Guanosine 3′,5′-cyclic monophosphate

ASJC Scopus subject areas

  • Physiology
  • Pulmonary and Respiratory Medicine
  • Physiology (medical)
  • Cell Biology

Cite this

Nitric oxide decreases endothelin-1 secretion through the activation of soluble guanylate cyclase. / Kelly, Lisa K.; Wedgwood, Stephen; Steinhorn, Robin H.; Black, Stephen M.

In: American Journal of Physiology - Lung Cellular and Molecular Physiology, Vol. 286, No. 5 30-5, 01.05.2004, p. L984-L991.

Research output: Contribution to journalArticle

Kelly, Lisa K. ; Wedgwood, Stephen ; Steinhorn, Robin H. ; Black, Stephen M. / Nitric oxide decreases endothelin-1 secretion through the activation of soluble guanylate cyclase. In: American Journal of Physiology - Lung Cellular and Molecular Physiology. 2004 ; Vol. 286, No. 5 30-5. pp. L984-L991.
@article{460813da166f4101924fa1caf3ec4d85,
title = "Nitric oxide decreases endothelin-1 secretion through the activation of soluble guanylate cyclase",
abstract = "The use of exogenous nitric oxide (NO) has been shown to alter the regulation of other endothelially derived mediators of vascular tone, such as endothelin-1 (ET-1). However, the interaction between NO and ET-1 appears to be complex and remains incompletely understood. One of the major actions of NO is the activation of soluble guanylate cyclase (sGC) with the subsequent generation of cGMP. Therefore, we undertook this study to test the hypothesis that NO regulates ET-1 production via the activation of the sGC/cGMP pathway. The results obtained indicated that the exposure of primary cultures of 4-wk-old ovine pulmonary arterial endothelial cells (4-wk PAECs) to the long-acting NO donor DETA NONOate induced both a dose- and time-dependent decrease in secreted ET-1. This decrease in ET-1 secretion occurred in the absence of changes in endothelin-converting enzyme-1 or sGC expression but in conjunction with a decrease in prepro-ET-1 mRNA. The changes in ET-1 release were inversely proportional to the cellular cGMP content. Furthermore, the NO-independent activator of sGC, YC-1, or treatment with a cGMP analog also produced significant decreases in ET-1 secretion. Conversely, pretreatment with the sGC inhibitor ODQ blocked the NO-induced decrease in ET-1. Therefore, we conclude that exposure of 4-wk PAECs to exogenous NO decreases secreted ET-1 resulting from the activation of sGC and increased cGMP generation.",
keywords = "Guanosine 3′,5′-cyclic monophosphate",
author = "Kelly, {Lisa K.} and Stephen Wedgwood and Steinhorn, {Robin H.} and Black, {Stephen M.}",
year = "2004",
month = "5",
day = "1",
doi = "10.1152/ajplung.00224.2003",
language = "English (US)",
volume = "286",
pages = "L984--L991",
journal = "American Journal of Physiology - Heart and Circulatory Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "5 30-5",

}

TY - JOUR

T1 - Nitric oxide decreases endothelin-1 secretion through the activation of soluble guanylate cyclase

AU - Kelly, Lisa K.

AU - Wedgwood, Stephen

AU - Steinhorn, Robin H.

AU - Black, Stephen M.

PY - 2004/5/1

Y1 - 2004/5/1

N2 - The use of exogenous nitric oxide (NO) has been shown to alter the regulation of other endothelially derived mediators of vascular tone, such as endothelin-1 (ET-1). However, the interaction between NO and ET-1 appears to be complex and remains incompletely understood. One of the major actions of NO is the activation of soluble guanylate cyclase (sGC) with the subsequent generation of cGMP. Therefore, we undertook this study to test the hypothesis that NO regulates ET-1 production via the activation of the sGC/cGMP pathway. The results obtained indicated that the exposure of primary cultures of 4-wk-old ovine pulmonary arterial endothelial cells (4-wk PAECs) to the long-acting NO donor DETA NONOate induced both a dose- and time-dependent decrease in secreted ET-1. This decrease in ET-1 secretion occurred in the absence of changes in endothelin-converting enzyme-1 or sGC expression but in conjunction with a decrease in prepro-ET-1 mRNA. The changes in ET-1 release were inversely proportional to the cellular cGMP content. Furthermore, the NO-independent activator of sGC, YC-1, or treatment with a cGMP analog also produced significant decreases in ET-1 secretion. Conversely, pretreatment with the sGC inhibitor ODQ blocked the NO-induced decrease in ET-1. Therefore, we conclude that exposure of 4-wk PAECs to exogenous NO decreases secreted ET-1 resulting from the activation of sGC and increased cGMP generation.

AB - The use of exogenous nitric oxide (NO) has been shown to alter the regulation of other endothelially derived mediators of vascular tone, such as endothelin-1 (ET-1). However, the interaction between NO and ET-1 appears to be complex and remains incompletely understood. One of the major actions of NO is the activation of soluble guanylate cyclase (sGC) with the subsequent generation of cGMP. Therefore, we undertook this study to test the hypothesis that NO regulates ET-1 production via the activation of the sGC/cGMP pathway. The results obtained indicated that the exposure of primary cultures of 4-wk-old ovine pulmonary arterial endothelial cells (4-wk PAECs) to the long-acting NO donor DETA NONOate induced both a dose- and time-dependent decrease in secreted ET-1. This decrease in ET-1 secretion occurred in the absence of changes in endothelin-converting enzyme-1 or sGC expression but in conjunction with a decrease in prepro-ET-1 mRNA. The changes in ET-1 release were inversely proportional to the cellular cGMP content. Furthermore, the NO-independent activator of sGC, YC-1, or treatment with a cGMP analog also produced significant decreases in ET-1 secretion. Conversely, pretreatment with the sGC inhibitor ODQ blocked the NO-induced decrease in ET-1. Therefore, we conclude that exposure of 4-wk PAECs to exogenous NO decreases secreted ET-1 resulting from the activation of sGC and increased cGMP generation.

KW - Guanosine 3′,5′-cyclic monophosphate

UR - http://www.scopus.com/inward/record.url?scp=1942485280&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1942485280&partnerID=8YFLogxK

U2 - 10.1152/ajplung.00224.2003

DO - 10.1152/ajplung.00224.2003

M3 - Article

C2 - 14695117

AN - SCOPUS:1942485280

VL - 286

SP - L984-L991

JO - American Journal of Physiology - Heart and Circulatory Physiology

JF - American Journal of Physiology - Heart and Circulatory Physiology

SN - 0363-6135

IS - 5 30-5

ER -